Mizuho (NYSE:MFG) analysts maintained a Neutral rating on Revance Therapeutics (NASDAQ:RVNC), a $382 million market cap company, with a steady price target of $3.65. The firm's stance came in the wake ...

Securities adjusted its outlook on Microsoft Corporation (NASDAQ:MSFT), reducing the tech giant's price target from $510 to ...

In a report released yesterday, Vijay Rakesh from Mizuho Securities maintained a Sell rating on Wolfspeed (WOLF – Research Report), with a ...

In a report released yesterday, Vijay Rakesh from Mizuho Securities reiterated a Buy rating on Tesla (TSLA – Research Report), with a price ...

Geneos Wealth Management Inc. lessened its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 8.3% during ...

an unusual move after serving as president of Mizuho Securities Co., a group company. Sakai pushed a corporate downsizing agenda, which included cutting staff and integrating or closing bank branches.

Yet "the bond market has not taken on board" the potential for 3% inflation in 2025, Steven Ricchiuto, chief economist at Mizuho Securities, wrote in a Monday client note. Even before December's ...

Mizuho Securities raised its recommendation on Vornado Realty Trust (NYSE:VNO) and Cousins Properties (NYSE:CUZ), and downgraded Kilroy Realty (NYSE:KRC), considering their geographic exposure and ...

For doing more than its peers to connect issuers and investors, Mizuho Securities is IFR’s Yen Bond House of the Year. Tightening currency basis swaps, easing geopolitical tensions between the US and ...

Qorvo (NASDAQ:QRVO) shares fell 0.5% in premarket trading on Friday, even as Mizuho Securities upped its earnings estimates on the involvement of activist investor Starboard Value. Mizuho analyst ...

Mizuho Financial Group, Inc. operates as a holding company which engages in the provision of financial services such as banking, trust banking, securities, and others. It operates through the ...